Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Nature Communications Année : 2020

Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins

Peter J. Lenting
Magali Toueille
  • Fonction : Auteur

Résumé

Targeted genome editing has a great therapeutic potential to treat disorders that require protein replacement therapy. To develop a platform independent of specific patient mutations, therapeutic transgenes can be inserted in a safe and highly transcribed locus to maximize protein expression. Here, we describe an ex vivo editing approach to achieve efficient gene targeting in human hematopoietic stem/progenitor cells (HSPCs) and robust expression of clinically relevant proteins by the erythroid lineage. Using CRISPR-Cas9, we integrate different transgenes under the transcriptional control of the endogenous α-globin promoter, recapitulating its high and erythroid-specific expression. Erythroblasts derived from targeted HSPCs secrete different therapeutic proteins, which retain enzymatic activity and cross-correct patients' cells. Moreover, modified HSPCs maintain long-term repopulation and multilineage differentiation potential in transplanted mice. Overall, we establish a safe and versatile CRISPR-Cas9-based HSPC platform for different therapeutic applications, including hemophilia and inherited metabolic disorders.
Fichier principal
Vignette du fichier
s41467-020-17552-3.pdf (1.4 Mo) Télécharger le fichier
Origine : Publication financée par une institution
Loading...

Dates et versions

inserm-02946890 , version 1 (23-09-2020)

Identifiants

Citer

Giulia Pavani, Marine Laurent, Anna Fabiano, Erika Cantelli, Aboud Sakkal, et al.. Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins. Nature Communications, 2020, 11 (1), pp.3778. ⟨10.1038/s41467-020-17552-3⟩. ⟨inserm-02946890⟩
80 Consultations
119 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More